In addition to the G6, which will either require no fingerstick calibration or just one calibration at launch, depending on the company’s ultimate FDA strategy, Dexcom is planning to complete ...
Medical device maker DexCom announced Tuesday that the company has received a de novo clearance from the FDA to sell its latest continuous glucose monitoring system — the G6 — that requires no ...
First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6 CGM, with no fingersticks* required ...
Dexcom CGM use is proven to improve glycemic control 1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results